Journal of Nuclear Medicine 2026DOI 10.2967/jnumed.126.272574

Tumor and Organ Dose Estimates from 177 Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial

Read paper
Install the JC extension to share a paper and gain Synapse AI insight right on the page.
Add to Chrome — free

Public discussion

Edward AndertonIndustry scientist
What is the difference between estimated absorbed dose and absorbed dose in this paper?
Jul 31, 2026